Group 1 - Huapei Power received a project intention letter from a domestic new energy vehicle company for a thermal management system PTC water heater, with an estimated sales amount of approximately 9 million yuan over a 5-year lifecycle starting from 2026 [1] - Antu Biotech obtained medical device registration certificates for products including "Cytomegalovirus IgM Antibody Test Kit" [1][2] - Yihong Technology adjusted the upper limit of its share repurchase price to 65.04 yuan per share, with a total repurchase amount of 6.9583 million yuan for 198,000 shares [2] Group 2 - Aihui Long received a medical device registration certificate for the Hepatitis B virus core antibody detection kit, valid until May 28, 2030 [2][3] - Quanxin Co. plans to engage in commodity futures hedging to mitigate raw material price fluctuations, with a maximum guarantee amount of 8 million yuan [3] - Jiahua Intelligent plans to lease idle assets in Dongguan for a total rental amount of approximately 6.3193 million yuan over 6 years [3] Group 3 - Qianjiang Biochemical announced the resignation of its chairman and a director, with a new chairman to be elected [4][5] - Aerospace Morning Light was suspended from participating in military procurement activities due to violations, with internal investigations underway [6] - Guang'an Aizhong intends to establish a fund with a total scale of 70.7 million yuan, focusing on distributed wind and solar power generation [7] Group 4 - Zhejiang Medicine plans to use up to 1 billion yuan of idle funds for entrusted wealth management, with a maximum investment period of 12 months [10] - Hengrui Medicine's subsidiary received approval for clinical trials of HRS9531 injection, aimed at treating type 2 diabetes patients [11] - Taiji Co. announced the purchase of 10 million yuan in wealth management products, with a minimum holding period of 6 months [12] Group 5 - Hong Kong-listed company Huichuang Pharmaceutical received approval for the clinical trial of a spray for treating primary premature ejaculation [26][27] - Haichuang Pharmaceutical's new drug application for a prostate cancer treatment was approved by the National Medical Products Administration [28] - Zhuhai Guanyu was selected as a designated supplier for low-voltage lithium batteries by SAIC Volkswagen [29] Group 6 - Huayi Technology opened a tax refund service for overseas travelers, enhancing its retail offerings [32] - Baobian Electric plans to transfer 90% of its subsidiary's shares for 137 million yuan [33] - Yiwei Communication intends to invest 100 million yuan to establish a wholly-owned subsidiary to enhance its strategic layout [34]

Group 1: Company Overview - The report focuses on Zhongke Shuguang (603019), a leading enterprise in China's core information infrastructure, primarily engaged in high-end computing, storage, security, and data center products [3][4] - The company is a top incubation platform of the Chinese Academy of Sciences, with investments in several high-quality assets covering the entire computing industry chain from chips to cloud services [4][5] - The company's net profit has shown stable long-term growth, with a revenue of 13.148 billion yuan in 2024, a year-on-year decrease of 8.4%, while net profit reached 1.911 billion yuan, a year-on-year increase of 4.1% [4] Group 2: Business Strategy and Growth - Zhongke Shuguang has focused on artificial intelligence infrastructure, achieving significant technological breakthroughs in smart computing services, forming a complete product capability system [5][6] - The company has a comprehensive layout in the autonomous controllable computing industry chain, with subsidiaries like Shuguang Data Creation and Haiguang Information leading in their respective fields [5][6] - The report projects that the company will achieve revenues of 15.663 billion, 19.837 billion, and 25.417 billion yuan from 2025 to 2027, with net profits of 2.846 billion, 3.803 billion, and 5.251 billion yuan respectively [9] Group 3: Industry Insights - The semiconductor industry is facing uncertainties due to tariff disturbances, with visibility for the second half of 2025 being low [10] - The storage market is showing positive trends in Q2 2025, with significant price increases for DDR4 memory [13] - The AI hardware demand is expected to remain strong, with recommendations to focus on leading companies in the AI hardware sector [14] Group 4: Digital Media and Gaming - Bilibili (09626) reported a 24% year-on-year increase in revenue for Q1 2025, driven by strong user engagement and growth in mobile gaming [15][16] - The company’s mobile game revenue increased by 76% year-on-year, highlighting the success of its exclusive game titles [17] - The advertising revenue also grew by 20% year-on-year, reflecting the platform's increasing influence and user engagement [19] Group 5: Travel and Tourism - Trip.com Group (09961) reported a 16% year-on-year increase in net operating revenue for Q1 2025, driven by strong domestic travel demand and recovery in international business [27][28] - The company is seeing significant growth in outbound travel bookings, exceeding pre-pandemic levels by over 20% [29] - The report forecasts net operating revenues of 61.6 billion, 69.4 billion, and 79.4 billion yuan from 2025 to 2027, with net profits of 16.5 billion, 20.2 billion, and 22.5 billion yuan respectively [30]

Group 1 - Company Zhongnan Media signed a government procurement contract worth 1.009 billion yuan for the supply of free textbooks and related teaching resources in Hunan Province for 2025, ensuring stable revenue for the company [1] - Company Zhongnan Media was established in December 2008, focusing on the publishing, distribution, and printing of publications [2] Group 2 - Company Tongling Nonferrous Metals announced the resignation of its general manager and deputy general manager due to higher-level assignments [3] - Company Tongling Nonferrous Metals was founded in November 1996, primarily engaged in the mining and processing of copper, iron, and sulfur gold [4] Group 3 - Company Xinyi Co. plans to reduce its shareholding by no more than 1% due to personal asset allocation needs [5] - Company Xinyi Co. was established in April 1996, specializing in the research, production, and sales of functional new materials based on organic synthetic resins [6] Group 4 - Company Xinhua Pharmaceutical received approval for the registration of ibuprofen suspension drops, a non-prescription drug for relieving fever and mild to moderate pain in children [7] - Company Xinhua Pharmaceutical was founded in November 1998, focusing on the sales of raw materials and intermediates, as well as chemical products [8] Group 5 - Company Emei Mountain A elected Tong Jianming as a director and appointed him as the general manager [9] - Company Emei Mountain A was established in October 1997, primarily engaged in tourism services, including ticket sales and hotel operations [10] Group 6 - Company Heng Rui Medicine announced the approval of its innovative drug, Regaglitin Metformin tablets, for market launch, aimed at improving blood sugar control in type 2 diabetes patients [11] - Company Heng Rui Medicine was founded in April 1997, focusing on the research, production, and sales of pharmaceuticals [12] Group 7 - Company Chongqing Rural Commercial Bank announced the approval of Tang Li's qualification as vice president [13] - Company Chongqing Rural Commercial Bank was established in June 2008, focusing on inclusive finance and corporate financial services [14] Group 8 - Company Weili Medical received certification from the Canadian Ministry of Health for its extraction bag, allowing legal sales in the Canadian market [15] - Company Weili Medical was founded in April 2004, specializing in the research, production, and sales of medical devices in various fields [16] Group 9 - Company Ailis received approval for its KRAS G12C inhibitor, a new drug for treating advanced non-small cell lung cancer [17] - Company Ailis was established in March 2004, focusing on innovative drug research and development in oncology [18] Group 10 - Company Renfu Pharmaceutical received registration certificates for two new drugs, including methylprednisolone tablets and hydrocodone ibuprofen tablets [19] - Company Renfu Pharmaceutical was founded in March 1993, focusing on the research, production, and sales of pharmaceuticals [20] Group 11 - Company Siwei Tuxin received multiple invention patent certificates from the National Intellectual Property Administration [21] - Company Siwei Tuxin was established in December 2002, focusing on navigation maps, intelligent driving, and automotive electronic chips [22] Group 12 - Company Changhong High-Tech received a warning letter from the Ningbo Securities Regulatory Bureau for failing to disclose related party transactions [23] - Company Changhong High-Tech was founded in June 2012, focusing on the research, production, and sales of styrene thermoplastic elastomers [24] Group 13 - Company Gansu Energy Chemical announced the resignation of its director and general counsel due to organizational adjustments [25] - Company Gansu Energy Chemical was established in December 1996, focusing on coal mining and sales [26] Group 14 - Company Shanghai Construction received land use rights for a residential project in Tianjin, with a total investment of approximately 330 million yuan [27] - Company Shanghai Construction was founded in June 1998, focusing on construction, design consulting, and real estate development [28] Group 15 - Company Chengdu Xian Dao announced that a major shareholder plans to increase its stake in the company by 25 to 50 million yuan [29] - Company Chengdu Xian Dao was established in February 2012, focusing on drug research and development services [30] Group 16 - Company Hunan Silver announced the resignation of its deputy general manager due to organizational adjustments [31] - Company Hunan Silver was founded in November 2004, focusing on the smelting and sales of silver and other precious metals [32] Group 17 - Company China Chemical reported a total contract amount of 123.017 billion yuan for the first four months of the year [33] - Company China Chemical was established in September 2008, focusing on construction engineering and modern services [34] Group 18 - Company Borui Pharmaceutical received a registration certificate for iodinated contrast agent injection [35] - Company Borui Pharmaceutical was founded in October 2001, focusing on the research and production of pharmaceutical intermediates and raw materials [36] Group 19 - Company Wanhua Chemical announced a technical transformation of its ethylene unit, aiming to diversify raw materials and enhance competitiveness [37] - Company Wanhua Chemical was established in December 1998, focusing on the research, production, and sales of polyurethane and fine chemicals [38] Group 20 - Company ST Houlv received approval for its injectable cephalosporin sodium to pass the consistency evaluation for generic drugs [39] - Company ST Houlv was founded in June 2005, focusing on drug research, production, and sales [40] Group 21 - Company Anka Intelligent announced a targeted reduction of capital for its subsidiary [41] - Company Anka Intelligent was established in May 2004, focusing on the research and development of power system solutions [42] Group 22 - Company Huaming Intelligent announced financial support for its subsidiary [43] - Company Huaming Intelligent was founded in August 2001, focusing on intelligent systems and services [44] Group 23 - Company Foton Motor received a central subsidy of 124 million yuan for promoting new energy vehicles [45] - Company Foton Motor was established in August 1996, focusing on vehicles and mobile equipment [46] Group 24 - Company Guangsheng Tang received a registration certificate for ritonavir tablets, used in HIV treatment [47] - Company Guangsheng Tang was founded in June 2001, focusing on the research and production of antiviral drugs [48] Group 25 - Company Kexing Pharmaceutical received FDA approval for clinical trials of its GB18 injection in the United States [49] - Company Kexing Pharmaceutical was established in August 1997, focusing on the research and production of recombinant protein drugs [50] Group 26 - Company Heng Rui Medicine announced the final price for its H-share public offering at 44.05 HKD per share [51] - Company Heng Rui Medicine was founded in April 1997, focusing on the research, production, and sales of pharmaceuticals [52] Group 27 - Company Wandong Medical elected a new chairman following the resignation of the previous chairman [53] - Company Wandong Medical was established in May 1997, focusing on the research, production, and sales of medical imaging equipment [54] Group 28 - Company Qixia Construction announced a plan to reduce its shareholding by no more than 3% [55] - Company Qixia Construction was founded in December 1999, focusing on real estate development and management [56] Group 29 - Company Dasheng Intelligent signed a contract worth 11.5 million yuan for a high-efficiency machine room project [57] - Company Dasheng Intelligent was established in March 1995, focusing on AIoT intelligent management platforms [58] Group 30 - Company Huashi Technology announced an extension of the detention period for its actual controller [59] - Company Huashi Technology was founded in June 1998, focusing on information system integration and technical services [60] Group 31 - Company Tianzhihang announced plans to increase capital for its subsidiary [61] - Company Tianzhihang was established in October 2010, focusing on orthopedic surgical navigation robots [62] Group 32 - Company Pingzhi Information signed a procurement framework agreement with China Mobile for base station antennas [63] - Company Pingzhi Information was founded in November 2002, focusing on communication equipment and services [64] Group 33 - Company Mengke Pharmaceutical received acceptance for its new drug application for a new antibacterial drug [65] - Company Mengke Pharmaceutical was established in August 2012, focusing on small molecule drug research [66] Group 34 - Company Kede Education announced a change in its actual controller to a state-owned asset supervision committee [67] - Company Kede Education was founded in January 2003, focusing on education services [68] Group 35 - Company Jinlong Automobile elected a new chairman following the board meeting [69] - Company Jinlong Automobile was established in October 1996, focusing on the production and sales of buses [70] Group 36 - Company Jushen Co. received dividends totaling 95.7 million yuan from its subsidiaries [71] - Company Jushen Co. was founded in November 2011, focusing on logistics and warehousing services [72] Group 37 - Company Qingyun Technology announced plans for shareholders to reduce their holdings by up to 4.5% [73] - Company Qingyun Technology was established in April 2012, focusing on cloud computing products and services [74] Group 38 - Company Shengdexintai received a procurement notice from Dongfang Electric for a project worth 234 million yuan [75] - Company Shengdexintai was founded in October 2001, focusing on the production and sales of energy equipment [76] Group 39 - Company Juzhi Technology announced a plan for a director to reduce his holdings by up to 400,000 shares [77] - Company Juzhi Technology was established in November 2007, focusing on machine vision equipment [78] Group 40 - Company Sanrenxing announced plans for shareholders to reduce their holdings by up to 3% [79] - Company Sanrenxing was founded in August 2003, focusing on integrated marketing services [80] Group 41 - Company Transsion Holdings announced plans to increase capital for its subsidiary by 70 million yuan [81] - Company Transsion Holdings was established in August 2013, focusing on smart terminal design and sales [82] Group 42 - Company Jinling Pharmaceutical received approval for its raw material drug for iron deficiency anemia [83] - Company Jinling Pharmaceutical was founded in September 1998, focusing on drug manufacturing and healthcare services [84] Group 43 - Company Xiyu Tourism announced plans for shareholders to reduce their holdings by up to 3% [85] - Company Xiyu Tourism was established in January 2001, focusing on tourism and scenic area management [86]

Investment Rating - The investment rating for the company is "Outperform the Market" [5] Core Views - The company demonstrated steady revenue growth in Q1 2025, with a revenue of 138.3 billion yuan, representing a year-on-year increase of 16.2%. However, the profit margin decreased compared to the previous year [1][9] - The company is strategically increasing investments in international platforms while maintaining flexibility in marketing strategies, which is expected to enhance growth opportunities [3][12] - The company is leveraging the recovery in inbound tourism and the growth of outbound travel, with significant increases in hotel bookings and international travel reservations [2][10] Revenue Breakdown - In Q1 2025, the company reported accommodation booking revenue of 55.4 billion yuan (+23.2%), transportation ticketing revenue of 54.2 billion yuan (+8.4%), and other income sources showing substantial growth [2][10] - Domestic hotel bookings continue to grow, with a double-digit increase in room nights, while outbound travel bookings have recovered over 120%, outpacing industry capacity growth [2][10] - The international platform saw a booking increase of over 60%, driven by favorable visa policies and a significant rise in inbound tourism [2][10] Profitability Analysis - The company's gross profit margin decreased by 0.8 percentage points year-on-year in Q1 2025, attributed to increased personnel costs and strategic investments in international expansion [3][11] - The sales expense ratio for Q1 was 21.4%, which is below the annual budget, indicating a flexible approach to marketing expenditures [3][11] - The company expects profit growth to lag behind revenue growth in the short term due to margin pressures, with a projected CAGR of 11% for profits versus 15% for revenue over the next three years [12] Financial Forecasts and Valuation - The company forecasts Non-GAAP net profits of 182 billion yuan, 209 billion yuan, and 244 billion yuan for 2025, 2026, and 2027 respectively, with corresponding dynamic PE ratios of 19, 16, and 14 times [12][19] - Revenue is expected to grow significantly, with projections of 61.6 billion yuan in 2025, 71.1 billion yuan in 2026, and 81.9 billion yuan in 2027, reflecting a robust growth trajectory [4][19] - The company maintains a strong cash flow position and is proposing an additional share buyback plan, indicating a commitment to shareholder returns [12]

Investment Rating - The investment rating for the company is "Outperform the Market" [5] Core Views - The company demonstrated steady revenue growth in Q1 2025, with a revenue of 138.3 billion yuan, representing a year-on-year increase of 16.2%. However, the profit margin decreased compared to the previous year [1][9] - The company is strategically increasing investments in international platforms while maintaining flexibility in marketing strategies, which is expected to enhance growth opportunities [3][12] - The company is leveraging the recovery in inbound tourism and the growth of outbound travel, with significant increases in hotel bookings and international travel reservations [2][10] Revenue Breakdown - In Q1 2025, the company reported accommodation booking revenue of 55.4 billion yuan (+23.2%), transportation ticketing revenue of 54.2 billion yuan (+8.4%), and other income sources showing substantial growth [2][10] - Domestic hotel bookings continue to grow, with a double-digit increase in room nights, while outbound travel bookings have recovered over 120%, outpacing industry capacity growth [2][10] - The international platform saw a booking increase of over 60%, driven by favorable visa policies and a significant rise in inbound tourism [2][10] Profitability Breakdown - The company's gross margin decreased by 0.8 percentage points year-on-year in Q1 2025, attributed to increased personnel costs and strategic investments in international platforms [3][11] - The sales expense ratio for Q1 was 21.4%, which is below the annual budget, indicating a flexible approach to marketing expenditures [3][11] - The company expects profit growth to lag behind revenue growth in the short term due to profit margin fluctuations, with a projected CAGR of 11% for profits versus 15% for revenue over the next three years [12] Financial Forecasts and Valuation - The company forecasts Non-GAAP net profits of 182 billion yuan, 209 billion yuan, and 244 billion yuan for 2025, 2026, and 2027, respectively, with corresponding dynamic PE ratios of 19, 16, and 14 [12][19] - The projected revenue for 2025 is 61.6 billion yuan, reflecting a 15.6% increase from the previous year [4][19] - The company maintains a strong cash flow position and is proposing an additional share buyback plan, indicating a positive outlook for shareholder returns [12][19]

Group 1 - Weiling Co., Ltd. announced that its subsidiary Tianjin Changling Mining Partnership acquired 74.3% of Hunan Linwu Jiayu Mining Co., Ltd. for 220 million yuan, focusing on non-ferrous and black metal mining and smelting [1] - Zhongnong Lihua plans to acquire at least 50% of Taizhou Agricultural Materials Co., Ltd., which will become a subsidiary upon completion of the acquisition [1] - Chaohongji is planning to issue H-shares on the Hong Kong Stock Exchange, with details yet to be finalized [1][2] Group 2 - Hong Sifang's subsidiary plans to invest approximately 1.49 billion yuan in a new production base in Suizhou High-tech Industrial Development Zone [3] - Shangwei New Materials announced that its major shareholder Jin Feng Investment Holdings intends to reduce its stake by up to 3%, equating to 12.1 million shares [4] - Yihe Jiaye has changed its name to Beijing Ruimaite Medical Technology Co., Ltd., effective from May 21 [5][6] Group 3 - Huaxi Energy reported that its controlling shareholder has been detained and is under investigation, with no longer holding any positions in the company [7][8] - Aofei Entertainment plans to invest 10 million yuan in a partnership for equity investment in Shenzhen Xuanyuan Technology Co., Ltd. [9] - Hangzhou Electric plans to reduce its shares by up to 1.93%, equating to 13.36 million shares [10] Group 4 - Jiuhua Tourism intends to raise up to 500 million yuan through a private placement for various projects, including hotel renovations and transportation upgrades [11] - Dingxin Communications elected Liu Min as the new chairman following the resignation of Wang Jianhua [12] - Jiewate plans to acquire 40.89% of Nanjing Tianyi Hexin Electronics for 319 million yuan [13] Group 5 - Darui Electronics intends to acquire 80% of Dongguan Weisi Technology Co., Ltd. through cash purchase and capital increase [14] - Tianzhihang's shareholders plan to reduce their stakes by up to 3%, with each shareholder intending to sell 679,000 shares [15][16] - ST Shilong will lift its risk warning and change its stock name to Shilong Industrial, with trading limits adjusted from 5% to 10% [17] Group 6 - Ningde Times announced the listing of its H-shares on the Hong Kong Stock Exchange, raising approximately 35.33 billion HKD [19][20] - Mingyang Electric's shareholders plan to reduce their stakes by up to 3.01%, totaling 941,000 shares [21] - Bohai Leasing intends to transfer 100% of Global Sea Containers Ltd. for 1.75 billion USD, focusing on optimizing its debt structure [21]

证券研究报告——晨会聚焦 2025 年 5 月 16 日 中银晨会聚焦-20250516 ■重点关注 【宏观经济】4 月金融数据点评*张晓娇 朱启兵。4 月新增社融和新增信贷 偏弱，主要是受美国关税政策冲击；但 4 月数据中仍反映出积极的财政政策 落地速度较快、居民购房需求仍在恢复趋势当中；5 月国内宏观政策加大宽 松力度、海外经贸形势出现较大变化，我们预计将提振二季度经济预期。 | 市场指数 | | | | --- | --- | --- | | 指数名称 | 收盘价 | 涨跌% | | 上证综指 | 3380.82 | (0.68) | | 深证成指 | 10186.45 | (1.62) | | 沪深 300 | 3907.20 | (0.91) | | 中小 100 | 6321.96 | (1.34) | | 创业板指 | 2043.25 | (1.92) | 行业表现（申万一级） | 指数名称 | 涨跌% | 指数名称 | 涨跌% | | --- | --- | --- | --- | | 美容护理 | 3.68 | 计算机 | (2.97) | | 煤炭 | 0.42 | 通信 | (2.45) ...

Core Insights - The A-share market showed mixed performance with the Shanghai Composite Index rising by 0.17% while the Shenzhen Component Index and the ChiNext Index fell by 0.13% and 0.12% respectively, with a total trading volume of 1,291.365 billion yuan [2][7] - The banking, beauty care, and pharmaceutical sectors led the gains, while the defense, computer, and machinery sectors experienced declines [2][7] - The Hang Seng Index fell by 1.87%, and the Hang Seng Technology Index dropped by 3.26%, indicating a challenging environment for Hong Kong stocks [2][7] - In the U.S., the Dow Jones decreased by 0.64%, while the S&P 500 and Nasdaq rose by 0.72% and 1.61% respectively, reflecting a mixed sentiment in the overseas markets [2][7] Industry Analysis - The electric power equipment sector saw a decrease in the total market value held by public funds, amounting to 276.574 billion yuan in Q1 2025, a decline of 14.21% quarter-on-quarter but a slight increase of 3.05% year-on-year [9][10] - The sector's overweight ratio fell to 3.29%, down 1.60 percentage points from the previous quarter, indicating a reduced preference among funds for this sector [9][10] - The top five and ten holdings in the electric power equipment sector showed an increase in concentration, with the CR5 and CR10 ratios rising to 68.70% and 75.59% respectively, while the CR20 ratio decreased [10][11] - The battery and photovoltaic equipment segments faced significant reductions in holdings, while the wind power equipment sector saw increased interest due to accelerated project implementations [11][12] Social Services Sector - The social services sector reported a total revenue of 190.795 billion yuan in 2024, reflecting a year-on-year growth of 6.95%, but the net profit dropped by 31.26% to 7.366 billion yuan [13][14] - The tourism and scenic area segment achieved a revenue of 35.423 billion yuan, up 15.24% year-on-year, with a net profit increase of 7.19% [13][14] - The hotel and catering segment, however, experienced a revenue decline of 1.49% to 29.853 billion yuan, with net profit falling by 19.73% [14][15] - The report suggests that the implementation of vacation policies and the expansion of the inbound consumption market will continue to drive growth in the tourism and related sectors [14][15]

营收增长利润承压，旅游景区业绩稳健 [Table_ReportType] ——社会服务行业 2024 年业绩综述报告[Table_ReportDate] [投资要点： Table_Summary] 社会服务板块全年业绩增收不增利。2024 年上市公司业绩出炉，社会 服务板块增收不增利，营业收入合计 1907.95 亿元，同比增长 6.95%， 在申万一级行业中排名第 3；归母净利润合计 73.66 亿元，同比下降 31.26%，在申万一级行业中排名第 22。 旅游及景区板块：2024 年旅游及景区板块实现营收 354.23 亿元，同比 +15.24%，归母净利润 16.73 亿元，同比+7.19%。五一黄金周居民旅游 热情高涨，旅游市场持续回暖。调休工作日的减少使得更多游客选择拼 假开启早鸟游或节末错峰游，推动长线游目的地表现亮眼，各地创新和 丰富消费场景，以多元供给激发消费潜力、市场活力，为游客带来深度 体验。 3288 酒店餐饮板块：2024 年酒店餐饮板块实现营收 298.53 亿元，同比- 1.49%，归母净利润 15.67 亿元，同比-19.73%。消费承压导致板块业绩 出现波动，全年表现不佳。行业 ...

Key Points - The report highlights a selection of stocks for May, including companies such as SF Holding (顺丰控股) and Guizhou Moutai (贵州茅台) as part of the recommended investment portfolio [1] - The macroeconomic analysis discusses the implications of the US tariff policy, emphasizing that the long-term trade deficit is primarily due to the dollar's status as the world's reserve currency, which has led to structural economic issues in the US [2][4][5] - The tourism sector shows strong recovery during the May Day holiday, with domestic travel reaching 314 million trips, a year-on-year increase of 6.4%, and total spending of 180.27 billion yuan, up 8.0% [6][7][8] - The report on Zhongke Electric (中科电气) indicates significant growth in net profit, with a projected net profit of 303 million yuan for 2024, representing a 626.56% increase year-on-year, driven by the expansion of its negative electrode business [10][11]